Klotho Therapeutics Company

Focused on development and commercialization of recombinant human Klotho proteins to prevent and treat kidney disease and other diseases.


Investors

Founded Date: 2016
Last Funding Type: Series A
Headquarters: San Diego, California, United States
Investors Number: 1
Technology: Geroscience
Employee Number: 1-10
Industry: Biotechnology, Health Care
Estimated Revenue: $1M to $10M
Last Funding Date: 2017
Funding Status: Early Stage Venture
Investor Type: Early Stage Venture
Total Funding: 10000000